Seipel Group Pty Ltd   Report issue

For profit
Founded: Brisbane Australia (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT02396160
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now